TipRanks
Go Ultimate55% OFF
FesariusTherapeutics logo

FesariusTherapeutics: Valuation, Funding & Investors

FesariusTherapeutics is a commercial-stage medical technology company focused on advancing dermal repair solutions. Its flagship product, DermiSphere™, is a hydrogel Dermal Regeneration Template (hDRT) cleared by the U.S. FDA in 2025 for managing various wound types.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$20M
Total Funding Rounds
1
Latest Funding Amount
$20M
Latest Funding Round
Series A

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jun 10, 2026Series A$20.00M―

Similar Companies

A snapshot of private companies similar to FesariusTherapeutics, helping you discover and navigate related company profiles.

Related News and Analysis